Evidence map›Paper›PMID 25231105›Full record

ReviewJournal of lipid research2015

Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Chi-Liang Eric Yen, David W Nelson, Mei-I Yen

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 148 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.Advances in experimental medicine and biology · 2024
    Review
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chi-Liang Eric YenDepartment of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706. Electronic address: yen@nutrisci.wisc.edu.
David W NelsonDepartment of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706.
Mei-I YenDepartment of Nutritional Sciences, University of Wisconsin-Madison, Madison, WI 53706.
University of Wisconsin–Madison · US

Funding

TRAINING IN NUTRITIONT32DK007665 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI GUY E GROBLEWSKI, Chi- Liang Eric Yen · 1993 to 2026
$9.2M
Intestinal Triacylglycerol Metabolism and Energy BalanceR01DK088210 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI YEN, CHI- LIANG ERIC · 2011 to 2015
$1.7M
NIDDK NIH HHS DK088210NIDDK NIH HHS R01 DK088210NIDDK NIH HHS T32 DK007665
6 · The paper itself

Abstract

The intestine plays a prominent role in the biosynthesis of triacylglycerol (triglyceride; TAG). Digested dietary TAG is repackaged in the intestine to form the hydrophobic core of chylomicrons, which deliver metabolic fuels, essential fatty acids, and other lipid-soluble nutrients to the peripheral tissues. By controlling the flux of dietary fat into the circulation, intestinal TAG synthesis can greatly impact systemic metabolism. Genes encoding many of the enzymes involved in TAG synthesis have been identified. Among TAG synthesis enzymes, acyl-CoA:monoacylglycerol acyltransferase 2 and acyl-CoA:diacylglycerol acyltransferase (DGAT)1 are highly expressed in the intestine. Their physiological functions have been examined in the context of whole organisms using genetically engineered mice and, in the case of DGAT1, specific inhibitors. An emerging theme from recent findings is that limiting the rate of TAG synthesis in the intestine can modulate gut hormone secretion, lipid metabolism, and systemic energy balance. The underlying mechanisms and their implications for humans are yet to be explored. Pharmacological inhibition of TAG hydrolysis in the intestinal lumen has been employed to combat obesity and associated disorders with modest efficacy and unwanted side effects. The therapeutic potential of inhibiting specific enzymes involved in intestinal TAG synthesis warrants further investigation.

Indexed as

AnimalsChylomicronsDiacylglycerol O-AcyltransferaseEnergy MetabolismGene Expression Regulation, EnzymologicHumansIntestinal AbsorptionIntestinal MucosaLipid MetabolismMiceTriglyceridesChylomicronsDGAT1 protein, humanDiacylglycerol O-AcyltransferaseTriglyceridesacyltransferasesgut hormonesobesitytriglyceride

Identifiers

PMID25231105
PMCPMC4340298
OpenAlexW1998719511

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.